ArticleCell communication and signaling : CCS2025

A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling.

Ylenia Ferrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.